# Copac Nigeria ltd · 66-41 · NIGERIA — FDA import alert red lists: firms subject to detention without physical examination For Copac Nigeria ltd · 66-41 · NIGERIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is NIGERIA; product code is 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is Plot K6 Apapa-Oshodi Expressway , Lagos, Ng-La NIGERIA, verified against its source on 2026-09-16. - **Firm:** Copac Nigeria ltd _(verified: appears in the quote below)_ - **Import alert:** 66-41 - **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S. - **Country:** NIGERIA _(verified: appears in the quote below)_ - **Address:** Plot K6 Apapa-Oshodi Expressway , Lagos, Ng-La NIGERIA _(verified: appears in the quote below)_ - **Date published:** 09/30/2009 _(verified: appears in the quote below)_ - **Product code:** 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: appears in the quote below)_ - **FDA notes:** 7/7/2008. Albabukum Powerder (Aspirin and Caffeine). This product is labeled to contain 100 sachets; each sachet containing acetylsalicylic acid 760 mg and caffeine 60 mg. This product is indicated for fast relief of pain; cold; headache and feverishness. There is yet no final monograph for internal analgesics. However; this and all other internal analgesic OTC drug products are requires to bear certain labeling including drug facts format (21CFR 201.66); the Reyes Syndrome Warning (21CFR 201.314). This product also does not comply with the tamper evident packaging requirements for OTC drugs (21CFR 211.132) _(verified: appears in the quote below)_ ## What the source says > Copac Nigeria ltd Date Published : 09/30/2009 Plot K6 Apapa-Oshodi Expressway , Lagos, Ng-La NIGERIA 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 09/30/2009 Notes: 7/7/2008. Albabukum Powerder (Aspirin and Caffeine). This product is labeled to contain 100 sachets; each sachet containing acetylsalicylic acid 760 mg and caffeine 60 mg. This product is indicated for fast relief of pain; cold; headache and feverishness. There is yet no final monograph for internal analgesics. However; this and all other internal analgesic OTC drug products are requires to bear certain labeling including drug facts format (21CFR 201.66); the Reyes Syndrome Warning (21CFR 201.314). This product also does not comply with the tamper evident packaging requirements for OTC drugs (21CFR 211.132) ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_190.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).